cemka > Publications > 2017

Classer les publications sur l'année

  • Économie de la santĂ©

    Ready-to-use pre-filled syringes of atropine for anaesthesia care in French hospitals – a budget impact analysis.

    BENHAMOU D, PIRIOU V, DE VAUMAS C, ALBALADEJO P, MALINOVSKY JM, DOZ M, LAFUMA A, BOUAZIZ H.

    Anaesth Crit Care Pain Med ; 2017;36(2);115-121

  • Pharmaco-EpidĂ©miologie

    The Use of Saxagliptin in People with Type 2 Diabetes in France: The Diapazon Epidemiological Study

    BALKAU B, CHARBONNEL B, PENFORNIS P, CHRAIBI N, LAHOUEGUE A, FAURE C, THOMAS-DELECOURT F, DETOURNAY B

    Diabetes Ther ; 2017;8(5);1147-1162

  • Pharmaco-EpidĂ©miologie

    Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes

    MOUTAIROU A, ROUSSEL R, CHARBONNEL  B,  LEYE A,  DETOURNAY B,  MOHAMMEDI K,  POTIER L

    Diabetes Metab ; 2017;43(4):392-394

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Excess mortality between 2007 and 2014 among patients with Clostridium difficile infection: a French health insurance database analysis

    BARBUT F, BOUEE S, LONGEPIERRE L, GOLDBERG M, BENSOUSSAN C, LEVY-BACHELOT L

    J Hosp Infect ; 2017;98(1):21-28

  • BiomĂ©trie et Analyses de bases de donnĂ©es

    Management and cost analysis of cancer patients treated with G-CSF: a cohort study based on the French national healthcare insurance database

    TILLEUL P,  JACOT W,  EMERY C, LAFUMA  A,  GOURMELEN J

    J Med Economics ; 2017;20(12):1261-1267

  • Pharmaco-EpidĂ©miologie

    Survey of clinical practice patterns in the management of 992 hyperthyroid patients in France

    GOICHOT B, BOUEE S, CASTELLO-BRIDOUX C, CARON P

    Eur Thyroid J ; 2017;6:152-159

  • Pharmaco-EpidĂ©miologie

    Pratique de l’autosurveillance glycĂ©mique en France: donnĂ©es d’une enquĂȘte nationale

    GUERCI B, BENHAMOU PY, DURAIN D, BAHLOUL A, JEANBAT V, DETOURNAY B

    Med Mal Metab ; 2017;11(5):458-467

  • Pharmaco-EpidĂ©miologie

    Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases

    BAUJAT G, CHOQUET R, BOUEE S, JEANBAT V, COUROUVE C, RUEL A, MICHOT C, LE QUAN SANG KH, LAPIDUS D, MESSIAEN C, LANDAIS P, CORMIER-DAIRE V

    Orphanet Journal of Rare Diseases ; 2017;12(1):123

  • SantĂ© Publique et EpidĂ©miologie

    Fuel poverty in France: Adapting an English Methodology to assess the health cost implications

    EZRATTY V, ORMANDY D, LAURENT MH, DUBURCQ A, LENCHI C, BOUTIERE F, CABANES PA, LAMBROZO J

    Indoor and Built Environment ; 2017;26(7):999-1008

  • Économie de la santĂ©

    Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era

    CACOUB P, VAUTIER M, DESBOIS AC, LAFUMA A, SAADOUN D

    Liver International ; 2017:37(12):1805-1813

  • SantĂ© Publique et EpidĂ©miologie

    Exposure of children to extremely low frequency magnetic fields in France: Results of the EXPERS study

    MAGNE I, SOUQUES M, BUREAU I, DUBURCQ A, REMY E, LAMBROZO J

    J Expo Sci Environ Epidemiol ; 2017;27(5):505-512